Delivery Order SPE2DB25D3005-SPE2DB25FQHBA
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zortress 0.5 mg tablets in unit dose packaging (60-count) under a firm fixed-price contract valued at $9,306.29, with an ultimate completion date of August 15, 2025. This non-set-aside award represents a continuation of pharmaceutical supply support through AmerisourceBergen's existing relationship with DLA. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.61 firm fixed-price delivery order is for the supply of the immunosuppressant drug Zortress (everolimus) 0.5 mg tablets, with a completion date of December 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency Troop Support Medical awarded a $3,755.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180618 Zortress 0.75 mg tablets in unit dose packaging of 60 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order is for the purchase of the specified pharmaceutical product and has a period of performance from September 14, 2023 through September 15, 2023. No major...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zortress 0.25 mg tablets, a medication used in organ transplant procedures. The contract has a ceiling value of $2,644.10 and a period of performance through May 14, 2025. The contract is not designated as a set-aside and was awarded through open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,803.97 firm fixed-price delivery order is for the supply of Zortress 0.75 mg tablet medication, with a period of performance ending on July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $356.65 to Amerisourcebergen Drug Corporation for the supply of 4562259712 Zortress 0.25 MG tablets in unit dose packaging of 60 tablets. The firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania by September 8, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its expertise in pharmaceutical distribution for the U.S. Department of Defense. No...
- The Defense Logistics Agency awarded a $713 delivery order to Amerisourcebergen Drug Corporation for 4561391855 Zortress 0.25 MG tablets to be delivered within a three-day period ending July 3, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency procures pharmaceuticals and other medical commodities in support of the U.S. Department of Defense healthcare system and readiness...
- This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB22FP7N6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zortress 0.5 mg tablet, a pharmaceutical product, with a ceiling value of $11,811.09 and a completion date of September 6, 2022. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating...
- The Defense Logistics Agency Troop Support Medical awarded a $6,664 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562217348 Zortress 0.75 MG tablets to be delivered from their Conshohocken, Pennsylvania facility by September 19, 2023. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA Troop Support Medical customers. No set aside designation or subcontractors were identified. This...